P227 ASTHMA EXACERBATION REDUCTION IN ADULTS WITH HIGH/LOW AIRWAY REVERSIBILITY FOLLOWING OMALIZUMAB TREATMENT: RESULTS FROM PROSPERO.
- Resource Type
- Article
- Source
- Annals of Allergy, Asthma & Immunology; 2019 Supplement, Vol. 123, pS41-S42, 2p
- Subject
- Language
- ISSN
- 10811206